search icon

    Market Snapshot

    • S&P Futures

      3,814.5

    • Dow Futures

      30,961

    • Nasdaq Futures

      11,557.75

    blog search icon

    Rockwell Medical, Inc.

    (NASDAQ:RMTI)

    $1.28

    $-0.01

    -0.78%

    Rockwell Medical, Inc. Chart

    RMTI Stock Price Today

    Rockwell Medical, Inc. (RMTI) stock declined over -0.78% intraday to trade at $1.28 a share on NASDAQ. The stock opened with a loss of -3.03% at $1.3 and touched an intraday high of $1.33, falling -0.78% against the last close of $1.29. The stock went to a low of $1.26 during the session.

    Stock Snapshot

    $1.29

    Prev. Close

    11 Million

    Market Cap

    $1.26

    Day Low

    $1.3

    Open

    8.54 Million

    Number of Shares

    $1.33

    Day High

    -

    P/E ratio

    -2.86

    EPS (TTM)

    0.24

    Cash Flow per Share

    3.64

    Free Float in %

    0.12

    Book Value

    17,624

    Volume

    Rockwell Medical, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$1.3$1.33$1.26$1.2817,600
    2022-06-30$1.32$1.32$1.26$1.2925,700
    2022-06-29$1.35$1.38$1.29$1.3591,700
    2022-06-28$1.55$1.64$1.32$1.36146,400
    2022-06-27$1.47$1.54$1.45$1.552,300
    2022-06-24$1.29$1.7$1.29$1.49199,300
    2022-06-23$1.31$1.38$1.26$1.3672,100
    2022-06-22$1.3$1.37$1.25$1.2841,800
    2022-06-21$1.32$1.36$1.3$1.3347,900
    2022-06-17$1.3$1.45$1.3$1.3387,500

    Contact Details

    30142 South Wixom road
    Suite 501
    Wixom, MI 48393
    United States

    Webiste:RMTI

    248 960 9009

    Company Information

    Employees-

    Beta1.17

    Sales or Revenue61.93 Million

    5Y Sales Change3.10%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryHealth Care Supplies

    About Company

    Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

    Frequently Asked Questions

    icon

    What is the current Rockwell Medical, Inc. (RMTI) stock price?

    Rockwell Medical, Inc. (NASDAQ: RMTI) stock price is $1.28 as of the last check on Friday, July 1. During the trading session, RMTI stock reached the peak price of $1.33 while $1.26 was the lowest point it dropped to.

    icon

    RMTI's industry and sector of operation?

    The NASDAQ listed RMTI is part of Health Care Supplies industry that operates in the broader Health Care sector. Rockwell Medical, Inc. , together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally.

    icon

    Who are the executives of RMTI?

    Dr. Raymond Dennis Pratt FACP, M.D.
    Chief Devel. Officer
    Dr. Russell H. Ellison M.D., M.Sc., MSc.
    Pres, CEO & Director
    Mr. Russell L. Skibsted M.B.A.
    Exec. VP, CFO & Chief Bus. Officer
    Mr. Michael DeYoung
    VP of Operations

    icon

    What is the RMTI stock price today?

    RMTI stock traded closed the last session at $1.28, which is $-0.01 or -0.78% lower than its previous close of $1.29. RMTI's current trading price is 2.40% lower than its 52-week high of $10.16 where as its distance from 52-week low of 1.25% is -87.40%.

    icon

    How many employees does RMTI have?

    Number of RMTI employees currently stands at -. RMTI operates from 30142 South Wixom road, Suite 501, Wixom, MI 48393, United States.

    icon

    Link for RMTI official website?

    Official Webiste of $RMTI is: https://www.rockwellmed.com

    icon

    How do I contact RMTI?

    RMTI could be contacted at RMTI operates from 30142 South Wixom road, Suite 501, Wixom, MI 48393, United States, or at phone #248 960 9009 and can also be accessed through its website.

    icon

    How many shares of RMTI are traded daily?

    RMTI stock volume for the day was 17,624 shares while in the previous session number of RMTI shares traded was 17,600 . The average number of RMTI shares traded daily for last 3 months was 66.19 Thousands.

    icon

    How much did RMTI change today?

    The percentage change in RMTI stock occurred in the recent session was -0.78% while the dollar amount for the price change in RMTI stock was $-0.01.

    icon

    What price range RMTI stock been trading in?

    In the recent session, the day high for RMTI stock was $1.33 while the low for RMTI stock touched on the day was $1.26.

    icon

    What is the market cap of RMTI currently?

    The market value of RMTI currently stands at 11 Million with its latest stock price at $1.28 and 8.54 Million of its shares outstanding.